Resumen
The objective of this study was to investigate the involvement of tyrosine phosphorylation in the hyposmotic stimulation of cardiac I Ks, a slowly activating delayed-rectifier K+ current that promotes repolarization of the action potential. The current was recorded from whole-cell-configured guinea-pig ventricular myocytes before, during, and after their exposure to solution whose osmolarity was 0.75 times normal. Exposure to hyposmotic solution caused a near-doubling of the amplitude of I Ks, with little change in the voltage dependence of current activation. Stable, hyposmotically stimulated I Ks (I Ks,Hypo) was decreased by broadspectrum tyrosine kinase (TK) inhibitors tyrphostin A23 (IC50 ≈ 5 μM) and tyrphostin A25 (IC50 15.8±1.6 μM) but not by TK-inactive tyrphostin analogs, suggesting that tyrosine phosphorylation is important for maintenance of the current. In agreement with that view, we found that the TK-inhibitor action on I Ks,Hypo was strongly antagonized by vanadate compounds known to inhibit phosphotyrosyl phosphatase. When myocytes were pretreated with TK inhibitors, the stimulation of I Ks was attenuated in a concentration-dependent manner. The attenuation was not due to concomitant attenuation of a stimulation of tyrosine phosphorylation because neither the stimulation of I Ks nor its rate of decay following removal of hyposmotic solution was affected by pretreatment with vanadates. We suggest that the stimulation of I Ks by hyposmotic solution is dependent on a basal tyrosine phosphorylation that modulates a swelling-induced I Ks-stimulatory signal and/or the receptivity of Ks channels to that signal.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 489-500 |
Número de páginas | 12 |
Publicación | Pflugers Archiv European Journal of Physiology |
Volumen | 456 |
N.º | 3 |
DOI | |
Estado | Published - jun. 2008 |
Nota bibliográfica
Funding Information:We thank Gina Dickie for excellent technical assistance and Dr. Adolfo Cavalié for insightful discussions. Funding for the study was provided by the Heart and Stroke Foundation of New Brunswick and by the Canadian Institutes of Health Research (CIHR). Sergey Missan was supported by a postdoctoral fellowship from the Nova Scotia Health Research Foundation.
ASJC Scopus Subject Areas
- Physiology
- Clinical Biochemistry
- Physiology (medical)
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't